Fucose Supplementation for Glut1 Deficiency Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
This is a single-center, randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy and safety of L-fucose supplementation in subjects with GLUT1 deficiency syndrome (GLUT1DS).
Who Is on the Research Team?
Rodrigo T. Starosta, MD, PhD
Principal Investigator
Oregon Health and Science University
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive L-fucose or placebo for 12 weeks, followed by a cross-over to the alternate treatment for another 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- L-fucose
How Is the Trial Designed?
2
Treatment groups
Active Control
Placebo Group
L-fucose for 12 weeks, followed by placebo for 12 weeks.
Placebo for 12 weeks, followed by L-fucose for 12 weeks.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Oregon Health and Science University
Lead Sponsor
Glut1 Deficiency Foundation
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.